StockData
Tvardi Therapeutics, Inc. logo

Tvardi Therapeutics, Inc. (TVRD) stock

TVRDNasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 13, 2026Score 6/30
$1.01−0.09 (-8.18%)

Close on Nov 17, 2026Market cap $13.47MP/E –Yield 0.00%

Tvardi Therapeutics EV/EBITDA

EV/EBITDA is enterprise value divided by EBITDA over the trailing twelve months.

Tvardi Therapeutics's EV/EBITDA was 67.4× on Jan 31, 2022, against 313.0× a year earlier.

EV/EBITDA at the end of each year

PeriodPeriod endValueChange (pts)
2022Jan 31, 202267.4×−3.9
2021Dec 31, 202171.4×−241.6
2014Apr 30, 2014313.0×–

More Tvardi Therapeutics figures

See a number that looks wrong?